ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 3 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 3.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $619,627 | -59.7% | 823,096 | -19.7% | 0.12% | -67.8% |
| Q3 2023 | $1,537,500 | -3.3% | 1,025,000 | +2.5% | 0.38% | +0.8% |
| Q2 2023 | $1,590,000 | +45.0% | 1,000,000 | -34.6% | 0.38% | +74.9% |
| Q1 2023 | $1,096,474 | +15.7% | 1,528,400 | -6.5% | 0.22% | +9.7% |
| Q4 2022 | $947,482 | +10.8% | 1,635,000 | +81.7% | 0.20% | +4.3% |
| Q3 2022 | $855,000 | -31.2% | 900,000 | -13.0% | 0.19% | -20.0% |
| Q2 2022 | $1,242,000 | – | 1,035,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 919,000 | $4,816,000 | 2.29% |
| RTW INVESTMENTS, LP | 6,256,840 | $32,786,000 | 2.24% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $2,515,000 | 1.08% |
| Bpifrance SA | 828,262 | $4,340,000 | 0.49% |
| WS MANAGEMENT LLLP | 888,722 | $4,657,000 | 0.28% |
| Eventide Asset Management | 1,146,580 | $6,008,000 | 0.21% |
| 683 Capital Management, LLC | 362,386 | $1,899,000 | 0.17% |
| Orbimed Advisors | 1,243,200 | $6,514,000 | 0.10% |
| Sofinnova Investments, Inc. | 159,237 | $835,000 | 0.08% |
| Rhenman & Partners Asset Management AB | 119,673 | $627,000 | 0.07% |